Hoth Therapeutics
(NASDAQ) HOTH
Hoth Therapeutics Financials at a Glance
Market Cap
$20.04MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.
Revenue (TTM)
$0.00
Net Income (TTM)
-$11.69M
EPS (TTM)
-$0.81
P/E Ratio
-1.11
Dividend
$0.00
Beta (Volatility)
0.99 (Low)
Dividend
$0.00
Beta (Volatility)
0.99 (Low)
Price
$0.90
Volume
5,459,746.107
Open
$0.89
Price
$0.90
Volume
5,459,746.107
Open
$0.89
Previous Close
$0.90
Daily Range
$0.82 - $0.92
52-Week Range
$0.49 - $2.45
Estimated Earnings Date
Sep 2, 2026
Dividend
$0.00
Beta (Volatility)
0.99 (Low)
Price
$0.90
Volume
5,459,746.107
Open
$0.89
Previous Close
$0.90
Daily Range
$0.82 - $0.92
52-Week Range
$0.49 - $2.45
Estimated Earnings Date
Sep 2, 2026
HOTH News
Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout Hoth Therapeutics
Industry
Pharmaceuticals
Sector
Health CareEmployees
6
CEO
Robbie Knie
Website
www.hoththerapeutics.comHeadquarters
New York, NY 10036, US
HOTH Financials
Key Financial Metrics (TTM)
Gross Margin
0.00%
Operating Margin
0.00%
Net Income Margin
0.00%
Return on Equity
-165.25%
Return on Capital
-180.48%
Return on Assets
-208.90%
Earnings Yield
-90.09%
Dividend Yield
0.00%
Payout Ratio
0.00%
Stock Overview
Market Cap
$20.04MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.
Shares Outstanding
22.32M
Volume
5.46M
Avg. Volume
12.22M
Financials (TTM)
Gross Profit
$0.00
Operating Income
-$11.53M
EBITDA
-$11.69M
Operating Cash Flow
-$10.07M
Capital Expenditure
$5.00
Free Cash Flow
-$10.07M
Cash & ST Invst.
$4.05M
Total Debt
$0.00
Hoth Therapeutics Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonCurrently no data to display.
Earnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonQuarterly Performance
Revenue
$0.00
N/A
Gross Profit
$0.00
N/A
Gross Margin
0.00%
N/A
Market Cap
$20.04MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.
N/A
Market Cap/Employee
$3.34M
N/A
Employees
6
N/A
Net Income
-$2.69M
+22.5%
EBITDA
-$2.69M
-1487649.7%
Quarterly Fundamentals
Total Cash
$4.05M
-64.2%
Total Debt
$0.00
-100.0%
Accounts Receivable
$0.00
-100.0%
Inventory
$0.00
N/A
Long Term Debt
$0.00
N/A
Short Term Debt
$0.00
-100.0%
Return on Assets
-2.09%
N/A
Return on Invested Capital
-2.77%
N/A
Free Cash Flow
-$3.05M
-9.4%
Operating Cash Flow
-$3.05M
-9.4%